Geoffrey S. Dow

Insider Reports History

Location: Washington, DC
Owner filing signature: /s/ Geoffrey Dow
Transaction evidence: Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Geoffrey S. Dow

Form 4 holding President and CEO, Director

60 DEGREES PHARMACEUTICALS, INC.

Security class: Common Stock
Shares / value: 59,618
Estimated value: $47,837
Report date: 15 Dec 2025
Price: $0.8024
Ownership: Direct

Form 4 holding President and CEO, Director

60 DEGREES PHARMACEUTICALS, INC.

Security class: Stock Option (Right to Buy)
Shares / value: 525,000
Estimated value
Report date: 02 Jan 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Geoffrey S. Dow

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 15 Dec 2025
Transactions: 1
Transaction value: +$7,759
Accepted by SEC: 16 Dec 2025, 17:41
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 10 Dec 2025
Transactions: 2
Transaction value: +$12,204
Accepted by SEC: 12 Dec 2025, 08:39
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 12 Sep 2025
Transactions: 1
Transaction value: +$9,996
Accepted by SEC: 15 Sep 2025, 16:38
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 09 Jun 2025
Transactions: 1
Transaction value: +$13,065
Accepted by SEC: 09 Jun 2025, 17:23
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 17 Jan 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 Jan 2025, 17:00
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 02 Jan 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 Jan 2025, 16:52
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 05 Dec 2024
Transactions: 3
Transaction value: +$89,755
Accepted by SEC: 09 Dec 2024, 17:07
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 19 Nov 2024
Transactions: 3
Transaction value: +$6,367
Accepted by SEC: 21 Nov 2024, 18:14
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 31 Jan 2024
Transactions: 2
Transaction value: +$10,000
Accepted by SEC: 02 Feb 2024, 15:33
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 21 Nov 2023
Transactions: 5
Transaction value: +$21,933
Accepted by SEC: 21 May 2024, 20:19
Role: President and CEO, Director
Next action: Open filing details

4 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 12 Jul 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Jul 2023, 14:51
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

3 SXTP

60 DEGREES PHARMACEUTICALS, INC.

Report period: 11 Jul 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 11 Jul 2023, 21:11
Role: CEO and President, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .